Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,186,348
-$7,751,414 QoQ
Shares Held
142,443
-69.2% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 328 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. HRMY ranks #33 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in HRMY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,186,348 | 142,443 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,937,762 | 461,898 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,478,322 | 306,743 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,635,828 | 277,062 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,982,760 | 252,619 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,218,710 | 187,367 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,367,628 | 214,113 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,218,840 | 155,471 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,754,731 | 157,598 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,854,291 | 144,559 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,500,811 | 139,344 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,245,933 | 99,052 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $11,222,054 | 318,899 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,064,080 | 155,102 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $13,058,809 | 237,002 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,941,646 | 269,624 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,216,563 | 229,989 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $5,739,240 | 117,970 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $709,572 | 16,641 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $238,795 | 6,230 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||